Literature DB >> 15349822

The Wnt connection to tumorigenesis.

Jürgen Behrens1, Barbara Lustig.   

Abstract

Wnt signaling has been identified as one of the key signaling pathways in cancer, regulating cell growth, motility and differentiation. Because of its widespread activation in diverse human tumor diseases, the Wnt pathway has gained considerable and growing interest in tumor research over recent years. Evidence that altered Wnt signaling is important for human tumor development came from three major findings: (i) the tumor suppressor adenomatous polyposis coli (APC) binds to the Wnt pathway component beta-catenin and is involved in its degradation, (ii) mutations of APC in colon tumors lead to stabilization of the beta-catenin protein and (iii) tumor-associated mutations of beta-catenin in colorectal cancer as well as in other tumor types lead to its stabilisation, qualifying beta-catenin as a proto-oncogene. Here we will describe the biochemical interactions which shape the Wnt pathway and focus on its role in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15349822     DOI: 10.1387/ijdb.041815jb

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  55 in total

1.  Targeting peptide termini, a novel immunoaffinity approach to reduce complexity in mass spectrometric protein identification.

Authors:  Sibylle Hoeppe; Thomas D Schreiber; Hannes Planatscher; Andreas Zell; Markus F Templin; Dieter Stoll; Thomas O Joos; Oliver Poetz
Journal:  Mol Cell Proteomics       Date:  2010-10-20       Impact factor: 5.911

2.  Down-regulation of some miRNAs by degrading their precursors contributes to anti-cancer effect of mistletoe lectin-I.

Authors:  Lin-Na Li; Hua-Dong Zhang; Run Zhi; Shou-Jun Yuan
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

3.  Aneuploidy-dependent massive deregulation of the cellular transcriptome and apparent divergence of the Wnt/beta-catenin signaling pathway in human rectal carcinomas.

Authors:  Marian Grade; B Michael Ghadimi; Sudhir Varma; Richard Simon; Danny Wangsa; Linda Barenboim-Stapleton; Torsten Liersch; Heinz Becker; Thomas Ried; Michael J Difilippantonio
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

4.  Molecular plasticity of beta-catenin: new insights from single-molecule measurements and MD simulation.

Authors:  Monica Ritco-Vonsovici; Abdessamad Ababou; Michael Horton
Journal:  Protein Sci       Date:  2007-07-27       Impact factor: 6.725

Review 5.  Molecular basis of the potential of mesalazine to prevent colorectal cancer.

Authors:  Carmine Stolfi; Roberto Pellegrini; Eleonora Franze; Francesco Pallone; Giovanni Monteleone
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

Review 6.  Intestinal epithelial cells in vitro.

Authors:  Dharam P Chopra; Alan A Dombkowski; Paul M Stemmer; Graham C Parker
Journal:  Stem Cells Dev       Date:  2010-01       Impact factor: 3.272

7.  Role of Wnt signaling in bone remodeling and repair.

Authors:  Paul S Issack; David L Helfet; Joseph M Lane
Journal:  HSS J       Date:  2007-12-08

8.  Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers.

Authors:  Zeng-Quan Yang; Gang Liu; Aliccia Bollig-Fischer; Ramsi Haddad; Adi L Tarca; Stephen P Ethier
Journal:  Int J Cancer       Date:  2009-10-01       Impact factor: 7.396

9.  Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.

Authors:  Feiyan Deng; Keming Zhou; Wenli Cui; Dong Liu; Yuqing Ma
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

10.  Snapshots of protein dynamics and post-translational modifications in one experiment--beta-catenin and its functions.

Authors:  Katrin Luckert; Frank Götschel; Peter K Sorger; Andreas Hecht; Thomas O Joos; Oliver Pötz
Journal:  Mol Cell Proteomics       Date:  2011-03-04       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.